Back to search
FDAFDA · Food and drugs·Recall number D-1285-2014

Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2

Published May 7, 2014 · Recall initiated: April 1, 2014

Summary

FDA records drug Class III recall D-1285-2014, published May 7, 2014 and initiated April 1, 2014. Recalling firm: Genesis Pharmaceutical, Inc.; Status: Terminated; Reported quantity: 461 Bottles; Lot: Lot 54, Exp: 1/14/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genesis Pharmaceutical, Inc.
Distributor
Nationwide
Lot
Lot 54, Exp: 1/14/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2 recalled?

Yes. FDA published recall D-1285-2014 on May 7, 2014. Reported hazard: Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.

What should I do if I have this product?

Voluntary: Firm initiated · Letter